Venkata Ramana Kotamraju Selected Research

Venkata Ramana Kotamraju Research Topics

Disease

26	Neoplasms (Cancer) 10/2021 - 08/2008
4	Carcinoma (Carcinomatosis) 12/2019 - 01/2017
4	Glioblastoma (Glioblastoma Multiforme) 10/2019 - 10/2011
4	Breast Neoplasms (Breast Cancer) 11/2017 - 12/2013
3	Neoplasm Metastasis (Metastasis) 11/2017 - 01/2015
3	Peritoneal Neoplasms 05/2017 - 10/2016
3	Prostatic Neoplasms (Prostate Cancer) 04/2016 - 09/2009
2	Necrosis 12/2019 - 01/2018
2	Brain Neoplasms (Brain Tumor) 01/2019 - 01/2018
2	Melanoma (Melanoma, Malignant) 11/2017 - 04/2016
2	Atherosclerotic Plaque (Atheroma) 04/2016 - 06/2009
1	Primitive Neuroectodermal Tumors (PNET) 10/2021
1	Glioma (Gliomas) 11/2017
1	Brain Injuries (Brain Injury) 01/2016
1	Pulmonary Arterial Hypertension 12/2014
1	Insulin Resistance 12/2013
1	Ovarian Neoplasms (Ovarian Cancer) 12/2013
1	Rupture 06/2009
1	Atherosclerosis 06/2009

Drug/Important Bio-Agent (IBA)

30	Peptides (Polypeptides)IBA 10/2021 - 08/2008
8	LigandsIBA 12/2019 - 01/2010
5	ferric oxide (iron oxide)IBA 10/2019 - 10/2010
5	Pharmaceutical PreparationsIBA 01/2019 - 09/2009
4	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2010
4	Neuropilin-1IBA 10/2016 - 12/2009
3	IntegrinsIBA 12/2017 - 12/2009
3	Blood Proteins (Serum Proteins)IBA 01/2013 - 06/2009
3	FibrinIBA 01/2013 - 03/2009
2	SilverIBA 10/2019 - 05/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2016
2	Albumin-Bound Paclitaxel FDA Link 10/2016 - 03/2009
2	N-end cysteine peptide tumor-homing peptideIBA 10/2016 - 01/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2016 - 03/2009
2	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 12/2009
2	cysteinyl-arginyl-glutamyl-lysyl-alanylIBA 01/2013 - 10/2010
2	Lysine (L-Lysine)FDA Link 09/2009 - 06/2009
2	Arginine (L-Arginine)FDA Link 09/2009 - 06/2009
2	MicellesIBA 06/2009 - 03/2009
1	Contrast MediaIBA 10/2021
1	nidogen (entactin)IBA 12/2019
1	CytokinesIBA 12/2019
1	Laminin (Merosin)IBA 12/2019
1	Fibronectins (Fibronectin)IBA 10/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019
1	TenascinIBA 10/2019
1	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2018
1	LipidsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	KLA peptideIBA 12/2017
1	Mannose ReceptorIBA 11/2017
1	Hyaluronic Acid (Hyaluronan)IBA 05/2017
1	Peptide Receptors (Peptide Receptor)IBA 04/2016
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2016
1	ElementsIBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	Proteoglycans (Proteoglycan)IBA 01/2016
1	SiliconIBA 06/2015
1	Biological ProductsIBA 01/2015
1	NeuropilinsIBA 01/2015
1	DisulfidesIBA 01/2015
1	fasudil (AT 877)IBA 12/2014
1	Investigational DrugsIBA 12/2014
1	Glucose (Dextrose)FDA LinkGeneric 12/2013
1	Therapeutic UsesIBA 10/2011
1	arginyl-threonyl-arginineIBA 01/2010
1	Amino Acids FDA Link 01/2010
1	Liposomes (Liposome)IBA 01/2010
1	cysteinylglycine (Cys-Gly)IBA 01/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2010
1	GoldIBA 01/2010
1	Phenobarbital (Luminal)FDA Link 06/2009
1	Cysteine (L-Cysteine)FDA Link 06/2009
1	Glutamic Acid (Glutamate)FDA Link 06/2009
1	Apolipoproteins E (ApoE)IBA 06/2009
1	Alanine (L-Alanine)FDA Link 06/2009
1	AlbuminsIBA 03/2009
1	Fluorescein (Funduscein)FDA LinkGeneric 03/2009

Therapy/Procedure

8	Therapeutics 12/2017 - 06/2009
3	Precision Medicine 12/2017 - 10/2010
1	Intravenous Injections 10/2021
1	Immunotherapy 01/2018
1	Micro-Electrical-Mechanical Systems 11/2017
1	Investigational Therapies (Experimental Therapy) 01/2017
1	Lasers (Laser) 01/2010
1	Intravenous Administration 08/2008